Das Deutsche Herzzentrum München ist eine Spezialklinik an der Technischen Universität München und eines der deutschlandweit führenden Zentren für Herz- und Kreislauferkrankungen. Bekanntheit erlangte es unter anderem durch die erste erfolgreiche Herztransplantation in Deutschland am 7. Mai 1981.

During the past decade, Deutsches Herzzentrum Muenchen conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 20 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 14 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deutsches Herzzentrum Muenchen" #1 sponsor was "Deutsches Herzzentrum Muenchen" with 90 trials, followed by "Abbott Medical Devices" with 12 trials sponsored, "Medtronic Bakken Research Center" with 8 trials sponsored, "Edwards Lifesciences" with 6 trials sponsored and "Competence Network for Congenital Heart Defects" with 6 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deutsches Herzzentrum Muenchen" #1 collaborator was "Technical University of Munich" with 8 trials as a collaborator, "German Federal Ministry of Education and Research" with 6 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 3 trials as a collaborator, "Medtronic" with 3 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Deutsches Herzzentrum Muenchen" are "Atrial Fibrillation" (24 trials), "Aortic Valve Stenosis" (17 trials), "Coronary Artery Disease" (14 trials), "Coronary Disease" (14 trials) and "Myocardial Infarction" (11 trials). Many other conditions were trialed in "Deutsches Herzzentrum Muenchen" in a lesser frequency.

Most popular intervention types in "Deutsches Herzzentrum Muenchen" are "Device" (99 trials), "Drug" (41 trials), "Procedure" (28 trials), "Other" (20 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Clopidogrel" (7 trials), "Bivalirudin" (4 trials), "Dabigatran" (3 trials) and "Evolocumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Deutsches Herzzentrum Muenchen" are 188 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Deutsches Herzzentrum Muenchen". 4 are not yet recruiting, 19 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 111 completed trials in Deutsches Herzzentrum Muenchen, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Deutsches Herzzentrum Muenchen, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 59 trials, and there were also 55 trials that are defined as “Not Applicable".

Deutsches Herzzentrum Muenchen has several departments that took part in Clinical trials: "Klinikum fuer Herz- & Kreislauferkrankungen" - 2 trials